Search for: rheumatoid arthritis methotrexate autoimmune disease biomarker gene expression GWAS HLA genes non-HLA genes
| ID | PMID | Title | PublicationDate | abstract |
|---|---|---|---|---|
| 3967439 | Total knee arthroplasty in 1984. | 1985 Jan | In total knee arthroplasty, as little bone as possible should be removed, all intact ligaments should be saved, and fixation by biologic ingrowth, rather than methylmethacrylate, should result in the lowest incidence of loosening. | |
| 6349551 | Are rheumatoid nodules caused by vasculitis? A study of 13 early cases. | 1983 Aug | Rheumatoid nodules are especially found in patients with seropositive rheumatoid arthritis (RA). It is often suggested that the genesis of these lesions is due to a vasculitis in smaller capillary vessels or venules. To test this hypothesis we studied fresh nodules in 13 patients, all with classical or definite RA. In 7 cases a total of 8 nodules were removed within 10 days of origin and in 6 other cases between 2 and 8 weeks. In the former group immunofluorescence was found in 5 out of 8 cases, and in the latter group 3 out of 6 were positive. Immunoglobulin deposition together with complement was found only in cases of 10 days' duration or less. No correlation was found with the patient's age or disease duration, ESR, ANA positivity, Rose titre, haemoglobulin, or use of prednisolone. In 3 out of 7 nodules younger than 7 days no palisade layer was found, whereas in older nodules this layer was always present. Vasculitis was not more frequently present in the cases with younger nodules. Our study does not support the hypothesis that vasculitis is the primary cause of nodules. | |
| 322242 | Floctafenine: a new analgesic for use in rheumatic diseases. | 1977 Feb | In a double-blind, single-dose, multiple cross-over study, floctafenine (200 mg) was shown to be an active analgesic and similar in potency to aspirin (600 mg). A graphic rating scale was used to measure pain relief. The use of such a scale without cut-off points at each end led to problems in the distribution of results. | |
| 6435641 | Inhibitory effect of IgM rheumatoid factor on immune complex solubilization capacity and i | 1984 Oct | Purified IgM rheumatoid factors (RF; 3 monoclonal and 2 polyclonal) were shown to inhibit, in a dose-dependent manner, 2 complement-mediated functions, i.e., the immune complex solubilization capacity and the inhibition of immune precipitation. Inhibition of immune complex solubilization capacity occurred only if RF was added at the same time as, but not after, addition of the complement source. Experimental evidence suggests that the effects of RFs were not related to their anticomplementary activity, but rather required the attachment of RF to the Fc region of the IgG molecule. Although no clinical data are available so far, it might be plausible that these newly described properties of RF have biologic relevance. | |
| 6316343 | Antibodies to the Epstein-Barr virus nuclear antigen and to rheumatoid arthritis nuclear a | 1983 Dec | Patients with seropositive rheumatoid arthritis (RA) have elevated titers of precipitating antibody toward an antigen designated RA nuclear antigen (RANA). Anti-RANA reactivity has been associated with prior Epstein-Barr virus (EBV) infection. Using the protein blot technique, we have identified, in extracts of WI-L2, an EBV+ nonproducer B-lymphoblast line, a Mr 80,000 polypeptide that is reactive with anti-RANA-containing sera. This same polypeptide can be recovered from RANA precipitin bands. The Mr 80,000 polypeptide appears to be EBV-associated, as a homologous antigen was detected in two other EBV+ cell lines, Daudi and Raji, but was not present in three EBV- human cell lines tested, HeLa, BJAB, and Ramos. Anti-RANA antibodies and antibodies reactive with the Mr 80,000 polypeptide also appear coincidently in the sera of individuals exhibiting an EBV infection (infectious mononucleosis). Further analysis of the RANA-associated Mr 80,000 polypeptide suggested its identity with the previously recognized EBV-associated nuclear antigen designated EBNA. The Mr 80,000 antigen shares with EBNA the properties of being a heat-stable, DNA binding protein. EBNA is traditionally assayed by a complement fixation reaction and anti-Mr 80,000 antibodies were shown to be reactive when a complement fixation assay was used in the immunoblot. Finally, when the Mr 80,000 antigen was used to absorb an anti-RANA/anti-EBNA serum, both antibodies were reduced. | |
| 6496454 | Loglinear modeling with inexpensive computing equipment. | 1984 Nov | Loglinear models are finding increasing application in the analysis of data from epidemiologic studies and increasing attention in statistics courses taken by epidemiologists in training. This paper describes a program for microcomputers, written in BASIC, which fits hierarchic loglinear models to categoric data organized into multiway contingency tables of any dimensionality. For each model specified by the user, the program can be directed to calculate and display 1) two goodness-of-fit statistics and their corresponding degrees of freedom and p values; 2) expected cell counts under the fitted model; 3) maximum likelihood estimates of the model's terms and, for saturated models, their standard errors; and 4) for models involving a dichotomous response variable, the corresponding logistic regression model. The program can be run on most microcomputers with at least 16K bytes of random access memory, including some costing less than $100. | |
| 1219993 | Metacarpophalangeal joint implants. III. Roentgenographic study of the in vivo function. | 1975 | With tomographic examination of the metacarpophalangeal joint in the straight lateral projection with maximum active extension and flexion, performed after the implantation of 42 Swanson and 41 Niebauer finger joint implants, it was possible to study the in vivo function of these implants. A method was devised to determine the position of the proximal phalanx in relation to the metacarpal bone in the plane of flexion. This was correlated to the ideal position of the proximal phalanx as determined for each of the implants in experimental studies and defined only by the implant axis of rotation. A displacement of the phalanx in the proximal and volar direction was found. Usually, this was more pronounced with fracture of the implant, and could be about 7-8 mm in each direction. The hinge of the Niebauer implant was found to bend significantly less than expected, indicating movements taking place in other parts of the implant. The two blocks of the midsection were found to move in relation to the adjacent bones. Indicating an insufficient intramedullary fixation of the stems, these findings explained why cortical erosions appeared at the sites where the stems were in close contact with the bone: dorsally in the metacarpal bone and volarly in the proximal phalanx. | |
| 4544646 | Observations on drug prescribing in rheumatoid arthritis. | 1974 Mar 9 | A total of 125 patients with rheumatoid arthritis were investigated about their drug therapy before referral to a specialist centre. Most referrals were from general practitioners. Only 47 of the patients had received salicylates as the first drug and 18 had never had them at all. Soluble aspirin was the preparation of salicylates most frequently prescribed (for 63 patients). Only 60 patients had been given an adequate dose and only 62 an adequate course of treatment with salicylates. In 28 patients salicylates had been stopped on account of side effects. About one-third of the patients had been prescribed oral corticosteroids.The referral letters were poor in giving details of past and present drug therapy, and there were serious omissions in reporting of previous side effects.Seventy-five general practitioners were asked to rate several currently marketed antirheumatic drugs in terms of effectiveness. Though prednisolone 15 mg daily ranked higher than aspirin 4 g daily the difference was not significant. The study shows the inadequacies of drug prescribing for rheumatoid arthritis in the Glasgow area. | |
| 7350807 | Identification of collagen subtypes in synovial fluid sediments from arthritic patients. | 1980 Jan | Collagen fibers in synovial fluid sediment were described a decade ago. Since then, tissue-specific collagen molecules (types) have been characterized. Techniques were devised to identify the collagen types in joint fluid sediment. Collagens were found in 12 of 17 pellets prepared from fluid aspirates from 17 knee joints of patients with various forms of arthritis. Collagen types I and III and polypeptide chains A and B (basement membrane collagen) were specifically identified in four of seven fluids from patients with active systemic lupus erythematosus (SLE) and in a single fluid from a patient with severe septic arthritis. This "collagen profile" was identical to that of rheumatoid synovium. Type II collagen, characteristic of hyaline articular cartilage, was found in two of six fluids from osteoarthritic joints. The presence of sufficient collagen (about 5 micrograms) to permit typing was correlated with roentgenographic evidence of joint space narrowing; the presence of the "synovial" collagen profile was correlated with decreased joint fluid pH. | |
| 3920879 | MR imaging of the craniocervical junction. | 1985 Mar | Craniocervical junctions in 35 abnormal and 10 normal subjects were studied with a 0.5 T superconducting magnetic resonance imaging system. Sagittal spin echo with 30 msec echo times and 500 msec repetition times constituted the most informative imaging plane and sequence. The anterior aspect of the foramen magnum was well delineated; the posterior margin was less constant in appearance. Compression and distortion of the medulla and upper cervical cord by bony and extramedullary lesions were seen easily. Intramedullary cysts were differentiated from solid tumors, but ventricular communication was evaluated less successfully because of partial-volume effect of the sections. Cerebellar ectopias were detected in some asymptomatic patients. | |
| 6348328 | Long-term silicone implant arthroplasty. Implications of animal and human autopsy findings | 1983 Sep 2 | An examination of host tissue response to implanted material has been conducted as part of a comprehensive research program to study low-modulus of elasticity silicone implants for small-joint arthroplasty. This was performed on animals and in a long-term human clinical evaluation. Autopsy material on three dogs was obtained more than ten years after silicone implants were placed in their limbs, and in one human arthritic patient it was obtained 12 years after hand reconstruction with implants. The benign nature of the tissue reaction to the implant material is noted. It is compared with other implant materials and discussed in terms of host tissue reactions that may occur in joint replacement procedures. | |
| 962422 | The anti-inflammatory profile of proquazone. | 1976 May | Proquazone, 1-isopropyl-4-phenyl-7-methyl-2(1H)-quinazolinone is an orally effective anti-inflammatory analgesic and antipyretic compound in animal models. The compound is less ulcerogenic than indomethacin in the rat and appears to potentiate the anti-inflammatory and thymus involution effects of hydrocortisone in this species. That a nonacidic nonsteroidal compound would display a spectrum of anti-inflammatory activity similar to that previously found only with acidic compounds will be the subject of further investigations. | |
| 7028987 | Sera from patients with systemic lupus erythematosus reactive with human endothelial cells | 1981 Jul | Human endothelial cells (EC) cultured from umbilical cord veins were reacted with sera from patients with systemic lupus erythematous (SLE), rheumatoid arthritis (RA) and normal persons. Immunofluorescent staining for IgG, IgM and IgA was then performed. Two types of control cells were also used, human foreskin fibroblasts and KB cells (a human carcinoma cell line). Sera from 9 of the 18 (50%) SLE patients showed cytoplasmic staining of EC for IgG. KB cells and fibroblasts did not stain. None of the RA or normal sera showed positive staining. In the 9 instances in which there was positive staining, 4 had evidence of cutaneous vasculitis. In contrast, none of the 9 patients without EC cytoplasmic staining had clinical evidence of cutaneous vasculitis. This data suggests that some SLE patients have an IgG antibody that reacts with EC cytoplasm which may be related to cutaneous vasculitis. | |
| 6788011 | Gold nephropathy. Ultrastructural, fluorescent, and energy-dispersive x-ray microanalysis | 1981 Jul | The nephrotic syndrome developed in a patient receiving therapy with gold for rheumatoid arthritis. The results of a histopathological examination of the renal biopsy specimen were unremarkable. Immunofluorescent studies showed deposits of immunoglobulins and C3 in a granular pattern in the glomerular basement membranes. Ultrastructurally, the discrete osmiophilic immune complexes were epimembranous. By x-ray microanalysis, gold that was complexed with sulfur was present in proximal tubular cytoplasmic vacuoles and nuclei. Gold and sulfur could not be demonstrated in glomerular epimembranous deposits. The results of these studies suggest that immune complex deposition does not involve gold and sulfur acting as haptens. Gold-salt therapy may result in damage to proximal tubules that leak renal tubular antigens, which in turn complex with autoantibody and produce an autoimmune membranous nephropathy. The evidence for this mechanism is not convincing. Although the data indicate an immune-complex cause for gold-salt nephropathy, the incident antigen (or antigens) and mechanism of action remain unidentified. | |
| 7351166 | [Pharmacokinetics of gold after administration of aurokeratinate (author's transl)]. | 1980 Jan 4 | Aurokeratinate (Auro-Detoxin) was administered intramuscularly to patients with chronic rheumatoid arthritis, using two different dosage schedules and measuring serum gold concentration. (1) Using slowly rising doses (as generally practised) the gold level gradually rose to 3.2 microgram/ml after four weeks (before the ninth injection), without reaching cumulation equilibrium. Elimination from serum occurred during this phase, with a half-life of 3-5 days. When treatment was continued at about 25 mg gold twice weekly, the cumulation equilibrium was reached with a minimal value at 3.5 microgram/ml and a maximal one of 6 microgram/ml, elimination half-life then being increased to nine days. During the subsequent maintenance treatment with 65 mg gold once a month the serum-gold concentration fell to about 1 microgram/ml, maximal values being about 6 microgram/ml, with an elimination half-life of 11 days. (2) With a constant dose of about 25 mg gold twice weekly, cumulation equilibrium was reached after two weeks (3.4 microgram/ml before the fifth injection), while on 50 mg gold every 14 days as maintenance dose the serum concentration was between 2 microgram/ml minimally and 6 microgram/ml maximally. At the modified dosage the drug was well tolerated. | |
| 6597049 | Phagocytosis, bactericidal capacity, and PGE2 production of monocytes in systemic lupus er | 1984 | Peripheral blood monocytes from 10 systemic lupus erythematosus (SLE) and 10 rheumatoid arthritis (RA) patients as well as from 24 controls were studied for such functions as phagocytosis, bactericidal capacity, iodination, and PGE2 production. Phagocytosis of opsonized erythrocytes, exploring only the Fc receptor, was increased in SLE and RA. Killing of Staphylococcus aureus was decreased in both SLE and RA in the presence of AB serum, but not in the presence of autologous serum. Iodination was, on the average, normal in SLE and elevated in RA. Prostaglandin E2 production was decreased in SLE (except with the highest concentration of Con A) and increased in RA. In SLE, functional alterations were more pronounced in clinically active than in inactive disease. These results show that in SLE and RA peripheral blood monocytes have alterations of their functions that are independent of serum factors. It is suggested that these abnormalities may be relevant to the pathogenetic mechanisms and evolution of these diseases. | |
| 6993675 | Benoxaprofen: once a day vs twice a day in patients with rheumatoid arthritis or osteoarth | 1980 | This multicenter clinical trial was conducted in patients with rheumatoid arthritis and osteoarthritis in an effort to evaluate and compare the efficacy and safety of benoxaprofen when taken as a single 600 mg dose in the evening or when taken in 2 300 mg doses. The results of the double-blind crossover studies demonstrated the effectiveness of the qd and bid dose and revealed no significant difference between the 2 dose regimens. They also showed the once-daily dose, a dose that is more convenient and easier to comply with, to be as effective as the twice-daily dose. | |
| 474195 | Resolution of renal amyloidosis secondary to rheumatoid arthritis. | 1979 | A patient with seronegative rheumatoid arthritis developed a nephrotic syndrome. Histological examination of renal biopsy disclosed moderate amyloidosis. Ultrastructurally the glomerular amyloid deposits were seen to be located both within the mesangium and subepithelially in the peripheral capillaries. The patient was treated with prednisone and cyclophosphamide for two years. The nephrotic syndrome remitted and a follow-up biopsy showed almost total disappearance of Congo red positive amyloid substance. Electron microscopy showed abundant finely granular material but only small amounts of fibrillar amyloid in the mesangial regions and intramembranous lucent areas containing few amyloid fibrils but no subepithelial deposits in the peripheral capillaries. We conclude that the mesangial amyloid substance was degraded to granular material and that the subepithelial amyloid deposits were resolved by mechanisms similar to those involved in the resolution of subepithelial immune complex deposits, i.e. through slow washing out and incorporation into the basement membrane. | |
| 6238599 | Characterization of the defective autologous mixed lymphocyte response in rheumatoid arthr | 1984 Nov | In order to characterize the autologous mixed lymphocyte response (AMLR) in patients with rheumatoid arthritis (RA) and to define the relationship with disease activity, peripheral blood T lymphocytes were stimulated with either a B lymphocyte-enriched (B cells) or a macrophage-enriched (macrophages) population. A significant reduction (P less than 0.01 to P less than 0.001) of T cell proliferation stimulated both by B cells and macrophages was observed in patients with active disease. The B lymphocytes were significantly less stimulatory (P less than 0.02 to P less than 0.001) than macrophages in the patients compared with the controls. In the normal controls, macrophages in higher concentrations were capable of suppressing the B lymphocyte-stimulated AMLR, but macrophages from patients with RA were not excessively suppressive. A significant association (P less than 0.02) was observed between disease activity and the AMLR. Using the B-enriched population, the AMLR proliferative response was significantly associated (P less than 0.001) with the production of interleukin-2. Defects in proliferation could only be partially restored by the addition of interleukin-2. These data indicate that the defective AMLR observed in patients with RA is related to disease activity and is associated with altered cellular interactions among T lymphocytes, macrophages, and the B lymphocyte-enriched population. | |
| 808577 | The quantitative distribution of gold in skin during chrysotherapy. | 1975 Sep | Gold concentrations in epidermis, dermis, and whole skin were measured by neutron activation analysis after formation of suction bullae in 8 patients who had received protracted cyrysotherapy. Epidermis contained 3% (median) of the gold content of whole skin. A direct correlation between cumulative gold dose and skin gold level was noted. These findings suggest that apparent gold concentrations in skin are influenced by the depth of the biopsy, that keratinous tissues have little affinity for gold, and that the gold storage capability of skin is not saturated by large cumulative doses of gold. The beneficial effect of gold in pemphigus may not be mediated at the site of blister formation. |